Metastatic Mucosal Melanoma Clinical Trials

8 clinical trials for Metastatic Mucosal Melanoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer — RECRUITING · PHASE1
• Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial — RECRUITING · PHASE2
• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases — RECRUITING · PHASE2
• Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease — ACTIVE_NOT_RECRUITING · PHASE1
• Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial — NOT_YET_RECRUITING · PHASE2
• Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases — TERMINATED · PHASE1
• Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma — TERMINATED · PHASE1

Refine this search